Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Peter Harper
✓ Verified Trust score 98/100 Accepting new patients

Dr

Dr Peter Harper

Oncology

5.00 · 5 verified reviews

English
12,217+ Patients seen
2 Years in practice
3 Publications
1 Languages spoken

About

Dr Peter Harper trained at University College and University College Hospital (MB BS 1970) and has been a leading consultant at Guy's and St Thomas Hospital for over 25 years. He is both an accredited physician and a medical oncologist. One of the four founder partners of the London Oncology Clinic, his vision was of a clinic dedicated solely to cancer treatment offering the highest international standards of care in a state-of-the-art supportive environment, also providing the support including all the ancillary care required by patients and their families.

Author of more than 400 papers and chapters in peer-reviewed publications, he is acknowledged globally for his work in researching new drugs and developing improved forms of cancer treatment. He has been the chair, or has been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications and is currently a member of eight pharmaceutical company advisory boards and is a member of sixteen professional bodies from around the world, including board membership of a committee of the American Society of Clinical Oncologists (ASCO).

In 2002 he was awarded the prestigious Cino del Duca Medal in 2004 in recognition of his work in developing new anti-cancer and vaccine therapies. For his role in advising the French Government in strategic cancer care (Board Member French National Cancer Institute), he was appointed a Chevalier of the Legion D'Honneur, a rare distinction for a foreign national. He remains on the board of INCA, the strategic committee for cancer treatment in France, and is currently the Chairman of the Toulouse Cancer Centre and holds the Medaille D'Or of that city.

Diseases, Medical Tests and Treatments
• Chemotherapy of solid tumours

• Gynaecological cancers

• Gastrointestinal cancers

• Breast cancer

• Lung cancer

• Urological cancers

• Chemotherapy of solid tumours

• Gynaecological cancers

• Gastrointestinal cancers

• Breast cancer

• Lung cancer

• Urological cancers

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Peter Harper

Education & training

  1. 2017–2023 MD · Medicine and Surgery
    UAB Barcelona (GB)
  2. 2023–2027 Residency · Oncology
    Universitat de València (GB)

Career & appointments

  1. 2027-09–2028-08 Junior consultant
    UAB Barcelona Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

GB — Organización Médica Colegial de España (OMC)
#GB-96038 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-52F0D0A1 · issued 2028 · renewal 2038
Malpractice insurance: AmTrust Europe · 4,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 1,657
Annual physical exam 99395 495
Vaccination administration 90471 247
Minor procedure (skin) 17110 256

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 90 min in_clinic 450.00 EUR
Minor procedure (skin) 60 min in_clinic 180.00 EUR

Office, team & in practice

Peter Harper
HEADSHOT
Peter Harper in consultation
IN OFFICE
Peter Harper with the team
WITH TEAM
Peter Harper at a conference
CONFERENCE

Videos

introduction · 98s
Meet Peter Harper

Research & publications

h-index: 3 · i10: 6

  1. Validation of clinical scoring in Oncology
    Peter Harper, et al. · European Journal of Medicine, 2026
    DOI: 10.2651/euroclin.2026.0 · PMID: 34994418 · cited by 73
  2. Long-term follow-up of Oncology across GB
    Peter Harper, et al. · European Journal of Medicine, 2025
    DOI: 10.3433/euroclin.2025.1 · PMID: 39310827 · cited by 51

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
  • 🏆 Excellence in Patient Care · National Society · 2024 · national

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2028
  • national college of family doctors — Member · since 2028
  • European Union of Medical Specialists (UEMS) — Member · since 2028

Patient reviews

★ 5.00 5 verified reviews
Bedside Manner
5.00
Knowledge
5.00
Wait Time
4.75
Staff Friendliness
5.00
Ease Of Appointment
4.90
Value For Money
4.92
Would Recommend Pct
99
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-01

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-04

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-15

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · dr.peter.harper@euroclinics.example
Accepted intl insurance
Allianz Worldwide · AXA Global · BUPA Global · Cigna Global

Similar specialists

Browse all →